American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders. 5th Edition. Arlington, NE.
Caputo F. et al. (2014b). Pharmacological management of alcohol dependence: From mono-therapy to pharmacogenetics and beyond. Eur Neuropsychopharmacol, 24: 181-191.
Caputo F. et al. (2019). Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol. Intern Emerg Med., 14: 143-160.
Caputo F. et al. (2020). Il trattamento farmacologico dei disordini da uso di alcol. Alcologia, 42: 38-64.
Patkar O.L. et al. (2019). Modulation of serotonin and noradrenaline in the BLA by pindolol reduces long-term ethanol intake. Addict Biol, 24: 652-663.
Scafato E. & Gruppo di lavoro CSDA (Centro Servizi Documentazione Alcol) (2024). Epidemiologia e monitoraggio alcol-correlato in Italia e nelle Regioni. Valutazione dell’Osservatorio Nazionale Alcol sull’impatto del consumo di alcol ai fini dell’implementazione delle attività del Piano Nazionale Alcol e Salute. Rapporto 2021. Roma: Istituto Superiore di Sanità; (Rapporti ISTISAN 24/3).
Scafato E. et al. (2020). The undertreatment of alcoholrelated liver diseases among people with alcohol use disorder. Eur Rev Med Pharmacol Sci., 24: 974-982.
Testino G. et al. (2020). Management of end-stage alcoholrelated liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol. Dig Liver Dis, 52: 21-32.
Testino G. et al. (2022). Alcohol use disorder in the Covid-19 era: position paper of the Italian Society on Alcohol. Addict Biol, 27, e13090.
Vignoli T. et al. (2024). Treatment of alcohol use disorder: position paper of the Società Italiana di Alcologia. Nutr Cur, 03 (Special 1), e150.